Karine Auclair | |
---|---|
Born | Jonquière, Québec, Canada |
Education | BSc, Chemistry, Université du Québec à Chicoutimi PhD, University of Alberta |
Scientific career | |
Institutions | McGill University |
Thesis | Biosynthetic studies on the polyketide lovastatin: enzyme-catalyzed diels-alder reactions (1999) |
Doctoral advisor | John C. Vederas |
Karine Auclair is a Canadian chemist. She holds a Tier 1 Canada Research Chair in Antimicrobials and Green Enzymes at McGill University.
Auclair was born and raised in Jonquière, Québec [1] [2] in a low-income family. [3] While she originally intended to pursue her Bachelor of Science abroad, her student visa was lost in the mail. [4] Auclair thus completed her Bachelor of Science in chemistry at Université du Québec à Chicoutimi and received the Governor General's Academic Medal for graduating with the highest grade point average. [5] Following her undergraduate degree, Auclair enrolled at the University of Alberta for her PhD in organic chemistry. [2] As both Auclair and her mother took a cholesterol-lowering agent for high blood pressure, her research focused on understanding how fungi naturally synthesized lovastatin. This resulted in her discovering the first enzyme to catalyze a Diels-Alder reaction. [3] Following her PhD, Auclair completed a post-doctoral fellowship in pharmaceutical chemistry at the University of California, San Francisco from 1999 to 2001. [2]
Auclair joined the Department of Chemistry at McGill University in 2002 as an assistant professor. [1]
Auclair was promoted to the rank of Full Professor in 2016. [6] Three years later, she was named a Tier 1 Canada Research Chair in Antimicrobials and Green Enzymes. [7] [8] In 2023, Auclair received the Clara Benson Award in recognition of her "distinguished contribution to chemistry while working in Canada." [1] She was also appointed to the Board of Directors of the French biochemistry company Carbios. [9]